Peripheral Neuropathy Trial, Recruiting (NCT06728787)

Peripheral Neuropathy Trial, Recruiting NCT06728787 Sponsor: IRCCS Eugenio Medea Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT06728787 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with Hereditary Spastic Paraplegia (HSP), either through genetic testing or based on clinical symptoms.
People who are older than 4 years and younger than 70 years of age.
People whose thigh bone (femur) measures more than 23 cm in length (confirm with trial site).
People who are able to walk on their own indoors, whether or not they use a walking aid such as a cane or walker.

Who may not be able to join:

People who have had botulinum toxin (Botox) injections or surgery on their lower limbs in the past 6 months.
People who have severe tightening or shortening of the muscles in their lower limbs.
People who have severe osteoporosis (very weak or brittle bones).
People who have open or unhealed skin wounds on their lower limbs.
People who have an unstable heart or cardiovascular condition.
People who have a neurological condition that is sudden (acute) or getting worse over time (progressive), separate from HSP.
People who have significant behavioural difficulties.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 3286859456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06728787

Sponsor: IRCCS Eugenio Medea

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: 3286859456

More information: https://clinicaltrials.gov/study/NCT06728787

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with Hereditary Spastic Paraplegia (HSP), either through genetic testing or based on clinical symptoms.
People who are older than 4 years and younger than 70 years of age.
People whose thigh bone (femur) measures more than 23 cm in length (confirm with trial site).
People who are able to walk on their own indoors, whether or not they use a walking aid such as a cane or walker.

Who may not be able to join:

People who have had botulinum toxin (Botox) injections or surgery on their lower limbs in the past 6 months.
People who have severe tightening or shortening of the muscles in their lower limbs.
People who have severe osteoporosis (very weak or brittle bones).
People who have open or unhealed skin wounds on their lower limbs.
People who have an unstable heart or cardiovascular condition.
People who have a neurological condition that is sudden (acute) or getting worse over time (progressive), separate from HSP.
People who have significant behavioural difficulties.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Eugenio Medea

Registry

ClinicalTrials.gov

Start date

1 January 2012

Est. completion

31 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Six-Minute Walk Test (6MWT); Six-Minute Walk Test (6MWT); Six-Minute Walk Test (6MWT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov